MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterised by hallmark neuropathologies including the presence of extracellular amyloid beta (Aβ) plaques, intracellular neurofibrillary tangles (NFT) composed of tau, a microtubule-associated protein, and progressive synaptic and neuronal loss.